Disclaimer: The information on this page is intended for Healthcare Professionals only.

A Conditional Marketing Authorisation (CMA) has been granted in the EU for the product COVID-19 Vaccine AstraZeneca for active immunisation of individuals aged 18 years and older for the prevention of coronavirus disease 2019 (COVID-19).

You can find more information here (https://www.ema.europa.eu/en).

Report an Adverse Event via the Medicines Authority ADR website

If you are concerned about an adverse event, it can be reported via the Medicines Authority ADR website:  http://medicinesauthority.gov.mt/adrportal

This link will take you to another website. AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.


AstraZeneca Vaccine Reporting